1,2-Dichloroethane → HCID 57889031, compound
Reaction equation
ClC1C=[CH:6][C:5]([C:8]2([OH:32])[CH2:13][CH2:12][N:11]([C:14](=[O:31])[C@H:15]([NH:19][C:20]([C:22]3[CH:23]=[C:24]([CH:28]=[CH:29][CH:30]=3)[C:25](O)=[O:26])=[O:21])[CH:16]([CH3:18])[CH3:17])[CH2:10]C2)=[CH:4]C=1.[CH:33]1[CH:34]=[CH:35][C:36]2N(O)N=N[C:37]=2[CH:38]=1.[CH2:43](Cl)[CH2:44]Cl.[ClH:47].[C:48]([O:51]NCC)(=[O:50])[CH3:49].CC[N:57](C(C)C)C(C)C>C(Cl)(Cl)Cl>[Cl:47][C:33]1[CH:34]=[CH:35][C:36]([C@@:8]2([OH:32])[CH2:13][CH2:12][N:11]([C:14](=[O:31])[C@H:15]([NH:19][C:20]([C:22]3[CH:23]=[C:24]([CH:28]=[CH:29][CH:30]=3)[C:25]([NH:57][CH2:49][C:48]([O:51][CH2:43][CH3:44])=[O:50])=[O:26])=[O:21])[CH:16]([CH3:17])[CH3:18])[CH2:10][C:5]2([CH3:4])[CH3:6])=[CH:37][CH:38]=1Participants
7
Procedure
(R)-3-(1-(4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl)-3-methyl-1-oxobutan-2-ylcarbamoyl)benzoic acid (30.5 mg, 0.06 mmol)), chloroform (1 mL), HOBT (9 mg, 0.06 mmol), EDC (20 mg, 0.13 mmol), ethylamino acetate hydrochloride, and DIPEA (32 mg, 0.25 mmol) was stirred at rt for 18 h. The product was purified directly via preparative reverse-phase HPLC.
Workup
- customThe product was purified directly via preparative reverse-phase HPLC
Sources & evidence
- ORD record
- ord-cdc4036bed294a02bab23a73607b1bda
- Source dataset
- uspto-grants-2009_10
- Patent number
- US07601844B2
Reaction notes
Loading…